We are live on
!
Find out more
SCM
Stevens Capital Management Portfolio holdings
AUM
$649M
1-Year Est. Return
27.37%
This Fund
S&P 500
This Quarter
Est. Return
+3.29%
1 Year Est. Return
+27.37%
3 Year Est. Return
+49.81%
5 Year Est. Return
+67%
10 Year Est. Return
+208.35%
AUM
$2.4B
AUM Growth
-$106M
(-4.2%)
Cap. Flow
-$130M
Cap. Flow
% of AUM
-5.42%
Top 10 Holdings %
Top 10 Hldgs %
12.59%
Holding
1,312
New
441
Increased
198
Reduced
233
Closed
436
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$36.6M |
| 2 |
Walt Disney
DIS
|
+$29.9M |
| 3 |
Monster Beverage
MNST
|
+$24.7M |
| 4 |
CELG
Celgene Corp
CELG
|
+$23.6M |
| 5 |
McKesson
MCK
|
+$22.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$29.1M |
| 2 |
Home Depot
HD
|
+$27.5M |
| 3 |
Nike
NKE
|
+$27.1M |
| 4 |
Pfizer
PFE
|
+$26M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$25.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 12.84% |
| 2 | Technology | 12.58% |
| 3 | Consumer Discretionary | 11.93% |
| 4 | Financials | 11.56% |
| 5 | Healthcare | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
476
Nike
NKE
$63.1B
| $793K | 0.03% |
15,070
-479,332
| -97% | -$27.1M |
|
|
DCH
477
Dauch Corp
DCH
$1.31B
| $788K | 0.03% |
45,785
+13,098
| +40% | +$220K |
|
|
AMWD
478
DELISTED
American Woodmark
AMWD
| $780K | 0.03% |
+9,687
| New | +$757K |
|
479
Eversource Energy
ES
$28.3B
| $777K | 0.03% |
14,334
-17,247
| -55% | -$973K |
|
480
Federated Hermes
FHI
$4.6B
| $775K | 0.03% |
26,166
+15,163
| +138% | +$475K |
|
481
Skywest
SKYW
$4.44B
| $774K | 0.03% |
+29,310
| New | +$814K |
|
482
BCE
BCE
$20.6B
| $771K | 0.03% |
16,687
-26,811
| -62% | -$1.27M |
|
483
Restaurant Brands International
QSR
$26B
| $769K | 0.03% |
17,240
-3,466
| -17% | -$157K |
|
|
FMBI
484
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $760K | 0.03% |
39,245
-1,175
| -3% | -$22.2K |
|
485
Neurocrine Biosciences
NBIX
$18.2B
| $758K | 0.03% |
+14,961
| New | +$745K |
|
|
SINA
486
DELISTED
Sina Corp
SINA
| $752K | 0.03% |
+10,191
| New | +$675K |
|
487
Adeia
ADEA
$2.65B
| $749K | 0.03% |
73,646
-46,792
| -39% | -$411K |
|
488
Aecom
ACM
$9.36B
| $748K | 0.03% |
+25,167
| New | +$811K |
|
489
Ciena
CIEN
$48.5B
| $747K | 0.03% |
34,274
-27,764
| -45% | -$579K |
|
490
BP
BP
$112B
| $740K | 0.03% |
+25,013
| New | +$726K |
|
491
Zimmer Biomet
ZBH
$18.6B
| $733K | 0.03% |
+5,810
| New | +$718K |
|
492
American Financial Group
AFG
$12B
| $728K | 0.03% |
9,701
+1,319
| +16% | +$97.3K |
|
493
Fortive
FTV
$18.7B
| $727K | 0.03% |
+22,645
| New | +$727K |
|
494
Sabra Healthcare REIT
SBRA
$5.62B
| $727K | 0.03% |
+28,876
| New | +$692K |
|
495
Selective Insurance
SIGI
$5.66B
| $723K | 0.03% |
18,139
-12
| -0.1% | -$472 |
|
496
Xerox
XRX
$360M
| $722K | 0.03% |
27,048
+12,518
| +86% | +$323K |
|
497
Under Armour Class C
UA
$2.84B
| $720K | 0.03% |
+21,276
| New | +$768K |
|
498
West Pharmaceutical
WST
$23.6B
| $717K | 0.03% |
9,619
-2,891
| -23% | -$230K |
|
|
DST
499
DELISTED
DST Systems Inc.
DST
| $714K | 0.03% |
+12,116
| New | +$733K |
|
500
News Corp Class A
NWSA
$15.6B
| $709K | 0.03% |
50,745
-411,221
| -89% | -$5.43M |
|
Similar funds
CCA
GAMA
TWP
ACA
CAAM
RK
PCM
ITC
Stevens Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Stevens Capital Management held 1,312 positions worth $2.4B, down 4.2% from $2.51B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Stevens Capital Management withdrew a net $130M in Q3 2016, closing 436 positions and reducing 233 holdings. Its most notable exit was Pfizer, an estimated $26M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Stevens Capital Management opened a new position in Monster Beverage worth $23.3M.
- Stevens Capital Management's largest Q3 2016 buy was Monster Beverage: 950,352 shares worth $23.3M.
- Stevens Capital Management added most to SLB Ltd in Q3 2016, an estimated $36.6M increase.
- Stevens Capital Management's biggest Q3 2016 reduction was Abbott, cutting an estimated $29.1M.
- Stevens Capital Management fully exited Pfizer in Q3 2016, selling an estimated $26M.
- Stevens Capital Management's ten largest holdings make up 13% of its $2.4B portfolio in Q3 2016.
- Stevens Capital Management opened 441 new positions and closed 436 in Q3 2016.
- Stevens Capital Management's portfolio value fell 4.2% quarter-over-quarter to $2.4B.
Based on Stevens Capital Management's 13F filing for Q3 2016, filed 8 Nov 2016.